First published 10/1/2026, 5:50:15 PM · Last updated 10/1/2026, 5:50:15 PM

Lifelong Epstein-Barr virus persistence as a stress test of ageing immune surveillance: from infectious mononucleosis to chronic active EBV disease and virus-associated malignancy

A journal article published by Elsevier BV on 2026-09-01 examines persistent Epstein-Barr virus infection in the context of ageing immune surveillance and discusses progression from acute infection to chronic active disease and virus-associated malignancy. The supplied metadata identifies the item as a journal article but provides no further study details or outcomes.

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 2/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 2/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

Understanding lifelong EBV persistence and immune ageing is relevant to research on chronic EBV disease and associated cancers.

Sources

Lifelong Epstein-Barr virus persistence as a stress test of ageing immune surveillance: from infectious mononucleosis to chronic active EBV disease and virus-associated malignancy

Report an issue